Drug intelligence / Profile preview

miR4458HG siRNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

miR4458HG siRNA is an experimental small interfering RNA designed to silence the long non-coding RNA (lncRNA) miR4458HG. In hepatocellular carcinoma (HCC), miR4458HG acts as an oncogene by binding to the m6A reader IGF2BP2, which stabilizes the transcripts of glycolytic enzymes such as hexokinase 2 (HK2) and glucose transporter 1 (GLUT1/SLC2A1). This activation of the glycolysis pathway fuels tumor cell proliferation and colony formation. Additionally, miR4458HG is secreted in exosomes to promote the M2-like polarization of tumor-associated macrophages by increasing ARG1 expression. By targeting miR4458HG, this siRNA inhibits these metabolic and microenvironmental pro-tumorigenic signals, suggesting a potential therapeutic strategy for HCC patients with high glucose metabolism.

Other names
si-miR4458HGsi-miR-4458HGsi-miR 4458HGsmall interfering RNA targeting miR4458HG
02

Targets

MIR4458HG (MIR4458 host gene)

Beyond the preview

Go deeper on miR4458HG siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR4458HG siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call